1. Home
  2. Products
  3. Customized FluoroAb™
  4. GD2
  5. Anti-GD2 MAb (Clone 3)-iFluor® 514 Succinimidyl Ester

Anti-GD2 MAb (Clone 3)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12341)

This product is comprised of an Chimeric Anti-GD2 IgG1-kappa (Clone 3) labeled with iFluor® 514 Succinimidyl Ester. iFluor® 514 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.

  • TARGET
  • ANTIBODY
  • DYE
  • Name
  • GD2
  • Alternative Names
  • Ganglioside GD2; GD2
  • Overview
  • GD2 is a disialic ganglioside expressed in tumors of neuroectodermal origin (including human neuroblastoma and melanoma), and its expression in normal tissues (mainly human cerebellum and peripheral nerves) is highly restricted.

    The relative tumor-specific expression of GD2 makes it a suitable target for immunotherapy using monoclonal antibodies or artificial T cell receptors. An example of such an antibody is hu14.18K322A, a monoclonal antibody. The anti-GD2 antibody is currently in phase II clinical trials for the treatment of previously untreated high-risk neuroblastoma and combined chemotherapy prior to stem cell transplantation and radiation therapy. A previous phase I clinical trial designed to reduce toxicity in patients with refractory or recurrent neuroblastoma found a safe dose and determined that common toxicity, especially pain, can be well controlled.
  • Overview
  • Chimeric Anti-GD2 IgG1-kappa (Clone 3)
  • Species Reactivity
  • Human
  • Name
  • iFluor® 514 Succinimidyl Ester
  • Color
  • Green
  • Excitation⁄Emission (nm)
  • 511/527
  • Detection method
  • Fluorescent

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for WJY0-LS12341. Click the button above to contact us or submit your feedback about this product.

Quick Links

Other Products

Same Target
CAT# Product Name Linker Payload
ADC-W-2006 Anti-GD2 (Dinutuximab)-SMCC-DM1 ADC SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
ADC-W-2010 Anti-GD2 (Dinutuximab)-MC-Vc-PAB-SN38 ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) SN-38 (7-ethyl-10-hydroxycamptothecin)
ADC-W-2009 Anti-GD2 (Dinutuximab)-MC-Vc-PAB-MMAE ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE
ADC-W-2008 Anti-GD2 (Dinutuximab)-MC-MMAF ADC MC (maleimidocaproyl) MMAF
ADC-W-2007 Anti-GD2 (Dinutuximab)-SPDB-DM4 ADC SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)

Online Inquiry

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.